MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $35,000 | 0.0% | 27,500 | 0.0% | 0.00% | – |
| Q3 2017 | $35,000 | 0.0% | 27,500 | 0.0% | 0.00% | – |
| Q2 2017 | $35,000 | -58.3% | 27,500 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $84,000 | -33.3% | 27,500 | -8.3% | 0.00% | 0.0% |
| Q4 2016 | $126,000 | -67.9% | 30,000 | -57.1% | 0.00% | -75.0% |
| Q2 2016 | $393,000 | -3.4% | 70,000 | +40.0% | 0.00% | -20.0% |
| Q1 2016 | $407,000 | -10.9% | 50,000 | -11.5% | 0.01% | 0.0% |
| Q4 2015 | $457,000 | -3.2% | 56,500 | +1.8% | 0.01% | -16.7% |
| Q3 2015 | $472,000 | -26.6% | 55,500 | +6.7% | 0.01% | -25.0% |
| Q2 2015 | $643,000 | +8.1% | 52,000 | +3.8% | 0.01% | +14.3% |
| Q1 2015 | $595,000 | -4.2% | 50,100 | -10.5% | 0.01% | -12.5% |
| Q4 2014 | $621,000 | +15.9% | 56,000 | -8.2% | 0.01% | +14.3% |
| Q3 2014 | $536,000 | +23.5% | 61,000 | +2.5% | 0.01% | 0.0% |
| Q2 2014 | $434,000 | +35.6% | 59,500 | -6.3% | 0.01% | +40.0% |
| Q1 2014 | $320,000 | +7.0% | 63,500 | +9.5% | 0.01% | 0.0% |
| Q4 2013 | $299,000 | +41.0% | 58,000 | +8.4% | 0.01% | +25.0% |
| Q3 2013 | $212,000 | -35.8% | 53,500 | +5.9% | 0.00% | -33.3% |
| Q2 2013 | $330,000 | – | 50,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |